Advertisement
Screener

ALPINE IMMUNE SCIENCES, INC. Operating Cash Flow

ALPINE IMMUNE SCIENCES, INC. Operating Cash Flow

ALPINE IMMUNE SCIENCES, INC. reported Operating Cash Flow of -$27.69 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-05-09

  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$27.69M.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$18.97M.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$15.80M.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$18.09M.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$79.01M.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$43.75M.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$15.25M, a 150.68% decline from fiscal 2020.
  • ALPINE IMMUNE SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2020 was $30.08M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2024-03-31-$27.69M
10-Q · filed 2024-05-09
-$46.66M
derived: sum of 2 quarters · filed 2024-05-09
-$62.46M
derived: sum of 3 quarters · filed 2024-05-09
-$80.55M
derived: sum of 4 quarters · filed 2024-05-09
2023-12-31-$18.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
-$34.77M
derived: sum of 2 quarters · filed 2024-03-20
-$52.86M
derived: sum of 3 quarters · filed 2024-03-20
-$79.01M
10-K · filed 2024-03-20
2023-09-30-$15.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$33.89M
derived: sum of 2 quarters · filed 2023-11-14
-$60.04M
10-Q · filed 2023-11-14
-$76.83M
derived: sum of 4 quarters · filed 2024-05-09
2023-06-30-$18.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$44.24M
10-Q · filed 2023-08-14
-$61.03M
derived: sum of 3 quarters · filed 2024-05-09
-$77.38M
derived: sum of 4 quarters · filed 2024-05-09
2023-03-31-$26.15M
10-Q · filed 2024-05-09
-$42.94M
derived: sum of 2 quarters · filed 2024-05-09
-$59.29M
derived: sum of 3 quarters · filed 2024-05-09
-$75.36M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$16.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
-$33.13M
derived: sum of 2 quarters · filed 2024-03-20
-$49.20M
derived: sum of 3 quarters · filed 2024-03-20
-$43.75M
10-K · filed 2024-03-20
2022-09-30-$16.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$32.42M
derived: sum of 2 quarters · filed 2023-11-14
-$26.97M
10-Q · filed 2023-11-14
-$41.70M
derived: sum of 4 quarters · filed 2024-03-20
2022-06-30-$16.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$10.62M
10-Q · filed 2023-08-14
-$25.35M
derived: sum of 3 quarters · filed 2024-03-20
$4.79M
derived: sum of 4 quarters · filed 2024-03-20
2022-03-31$5.45M
10-Q · filed 2023-05-11
-$9.28M
derived: sum of 2 quarters · filed 2024-03-20
$20.85M
derived: sum of 3 quarters · filed 2024-03-20
$6.17M
derived: sum of 4 quarters · filed 2024-03-20
2021-12-31-$14.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
$15.40M
derived: sum of 2 quarters · filed 2024-03-20
$723.00K
derived: sum of 3 quarters · filed 2024-03-20
-$15.25M
10-K · filed 2024-03-20
2021-09-30$30.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$15.45M
derived: sum of 2 quarters · filed 2022-11-14
-$519.00K
10-Q · filed 2022-11-14
-$9.87M
derived: sum of 4 quarters · filed 2023-03-23
2021-06-30-$14.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
-$30.65M
10-Q · filed 2022-08-11
-$40.00M
derived: sum of 3 quarters · filed 2023-03-23
-$45.39M
derived: sum of 4 quarters · filed 2023-03-23
2021-03-31-$15.97M
10-Q · filed 2022-05-12
-$25.32M
derived: sum of 2 quarters · filed 2023-03-23
-$30.71M
derived: sum of 3 quarters · filed 2023-03-23
$23.81M
derived: sum of 4 quarters · filed 2023-03-23
2020-12-31-$9.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
-$14.74M
derived: sum of 2 quarters · filed 2023-03-23
$39.78M
derived: sum of 3 quarters · filed 2023-03-23
$30.08M
10-K · filed 2023-03-23
2020-09-30-$5.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$49.13M
derived: sum of 2 quarters · filed 2021-11-10
$39.43M
10-Q · filed 2021-11-10
$33.76M
derived: sum of 4 quarters · filed 2022-03-17
2020-06-30$54.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
$44.83M
10-Q · filed 2021-08-10
$39.15M
derived: sum of 3 quarters · filed 2022-03-17
$28.58M
derived: sum of 4 quarters · filed 2022-03-17
2020-03-31-$9.69M
10-Q · filed 2021-05-13
-$15.37M
derived: sum of 2 quarters · filed 2022-03-17
-$25.94M
derived: sum of 3 quarters · filed 2022-03-17
-$33.82M
derived: sum of 4 quarters · filed 2022-03-17
2019-12-31-$5.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
-$16.25M
derived: sum of 2 quarters · filed 2022-03-17
-$24.12M
derived: sum of 3 quarters · filed 2022-03-17
-$35.35M
10-K · filed 2022-03-17
2019-09-30-$10.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
-$18.45M
derived: sum of 2 quarters · filed 2020-11-12
-$29.68M
10-Q · filed 2020-11-12
-$39.07M
derived: sum of 4 quarters · filed 2021-03-18
2019-06-30-$7.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
-$19.10M
10-Q · filed 2020-08-11
-$28.50M
derived: sum of 3 quarters · filed 2021-03-18
-$35.87M
derived: sum of 4 quarters · filed 2021-03-18
2019-03-31-$11.22M
10-Q · filed 2020-05-14
-$20.62M
derived: sum of 2 quarters · filed 2021-03-18
-$27.99M
derived: sum of 3 quarters · filed 2021-03-18
-$35.21M
derived: sum of 4 quarters · filed 2021-03-18
2018-12-31-$9.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
-$16.77M
derived: sum of 2 quarters · filed 2021-03-18
-$23.98M
derived: sum of 3 quarters · filed 2021-03-18
-$28.42M
10-K · filed 2021-03-18
2018-09-30-$7.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$14.59M
derived: sum of 2 quarters · filed 2019-11-14
-$19.02M
10-Q · filed 2019-11-14
-$24.86M
derived: sum of 4 quarters · filed 2020-03-30
2018-06-30-$7.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
-$11.65M
10-Q · filed 2019-08-13
-$17.48M
derived: sum of 3 quarters · filed 2020-03-30
-$22.17M
derived: sum of 4 quarters · filed 2020-03-30
2018-03-31-$4.43M
10-Q · filed 2019-05-09
-$10.27M
derived: sum of 2 quarters · filed 2020-03-30
-$14.95M
derived: sum of 3 quarters · filed 2020-03-30
-$18.84M
derived: sum of 4 quarters · filed 2020-03-30
2017-12-31-$5.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
-$10.52M
derived: sum of 2 quarters · filed 2020-03-30
-$14.41M
derived: sum of 3 quarters · filed 2020-03-30
-$16.57M
10-K · filed 2020-03-30
2017-09-30-$4.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$8.57M
derived: sum of 2 quarters · filed 2018-11-08
-$10.73M
10-Q · filed 2018-11-08
-$12.50M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30-$3.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$6.05M
10-Q · filed 2018-08-09
-$11.63M
10-Q · filed 2017-07-21
-$7.82M
derived: sum of 3 quarters · filed 2019-03-18
$3.71M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31-$2.16M
10-Q · filed 2018-05-14
-$3.93M
derived: sum of 2 quarters · filed 2019-03-18
$7.60M
derived: sum of 3 quarters · filed 2019-03-18
2016-12-31-$1.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$9.76M
derived: sum of 2 quarters · filed 2019-03-18
-$3.80M
10-K · filed 2019-03-18
2016-09-30$11.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
-$2.03M
10-Q · filed 2017-11-14
2016-06-30-$13.56M
10-Q · filed 2017-07-21
2015-12-31$4.82M
10-K · filed 2018-03-28